Latest Articles
Tobin Arthur • January 10, 2019

Early stage investing is not only inefficient, but almost entirely driven by varying levels of guesswork and amateur efforts. In the meantime, virtually every other industry is getting smarter through the adoption of big data or artificial intelligence (A.I.). The primary goal of AngelMD is to revolutionize early stage investing into a legitimate asset class, ...
Read more

LinkedInTwitterFacebook
Team angelMD • January 8, 2019

Today AngelMD announced that it completed a syndicate investment comprised of its members into Noninvasix. This represents the second investment AngelMD has made into Noninvasix in the past year. To reduce the incidence of neonatal mortality and morbidity, Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure brain oxygenation in preterm babies ...
Read more

LinkedInTwitterFacebook
Brad McCarty • December 12, 2018

Dr. Jeffrey Ross is a physician with a penchant for investing. He entered into private practice in 2008, and until 2017 he worked as an Interventional Radiologist. We recently had the opportunity to talk with Dr. Ross about his clinical work, his mindset as an investor, and now his new role as the Senior Vice ...
Read more

LinkedInTwitterFacebook